Note 1. Description of Business	6 Months Ended
Jun. 30, 2011
Nature of Operations [Text Block]	1. DESCRIPTION OF BUSINESS Oncothyreon Inc. (the “Company”) is a clinical-stage biopharmaceutical company incorporated in the State of Delaware on September 7, 2007. The Company is focused primarily on the development of therapeutic products for the treatment of cancer. The Company’s goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. Its operations are not subject to any seasonality or cyclicality factors.

Note 1. Description of Business

6 Months Ended

Jun. 30, 2011

1. DESCRIPTION OF BUSINESS

Oncothyreon Inc. (the “Company”) is a clinical-stage biopharmaceutical company incorporated in the State of Delaware on September 7, 2007. The Company is focused primarily on the development of therapeutic products for the treatment of cancer. The Company’s goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. Its operations are not subject to any seasonality or cyclicality factors.